OBJECTIVES: To examine gender differences in sexual behaviour, the prevalence of laboratory-detected sexually transmitted infections (STIs) and self-reported genital symptoms in urban Chennai, Tamil Nadu, India. STUDY DESIGN: The data were based on a cross-sectional survey (n = 1649) of residents from low-income communities in Chennai. Data were collected during community-wide health camps comprising physical examinations, interviews and laboratory testing between March and June 2001. RESULTS: The population was young, sexually active, with a low prevalence of STI. The most commonly detected STI was Herpes simplex virus type 2 (HSV2; 13.2%). Women had a higher prevalence of HSV2, but were more likely than men to be asymptomatic. Most of the self-reported genital symptoms could not be linked to a laboratory-detected STI. >10% of the cohort had a history of an ulcerative STI and >5% had an inflammatory STI. CONCLUSIONS: Given a high prevalence of HSV2 in the study population, interventions targeting HSV2 transmission may be particularly relevant for this population.
OBJECTIVES: To examine gender differences in sexual behaviour, the prevalence of laboratory-detected sexually transmitted infections (STIs) and self-reported genital symptoms in urban Chennai, Tamil Nadu, India. STUDY DESIGN: The data were based on a cross-sectional survey (n = 1649) of residents from low-income communities in Chennai. Data were collected during community-wide health camps comprising physical examinations, interviews and laboratory testing between March and June 2001. RESULTS: The population was young, sexually active, with a low prevalence of STI. The most commonly detected STI was Herpes simplex virus type 2 (HSV2; 13.2%). Women had a higher prevalence of HSV2, but were more likely than men to be asymptomatic. Most of the self-reported genital symptoms could not be linked to a laboratory-detected STI. >10% of the cohort had a history of an ulcerative STI and >5% had an inflammatory STI. CONCLUSIONS: Given a high prevalence of HSV2 in the study population, interventions targeting HSV2 transmission may be particularly relevant for this population.
Authors: Shruti H Mehta; Amita Gupta; Seema Sahay; Sheela V Godbole; Smita N Joshi; Steven J Reynolds; David D Celentano; Arun Risbud; Sanjay M Mehendale; Robert C Bollinger Journal: J Acquir Immune Defic Syndr Date: 2006-01-01 Impact factor: 3.731
Authors: Matthew R Golden; Rhoda Ashley-Morrow; Paul Swenson; Wayne R Hogrefe; H Hunter Handsfield; Anna Wald Journal: Sex Transm Dis Date: 2005-12 Impact factor: 2.830
Authors: David Serwadda; Ronald H Gray; Nelson K Sewankambo; Fred Wabwire-Mangen; Michael Z Chen; Thomas C Quinn; Tom Lutalo; Noah Kiwanuka; Godfrey Kigozi; Fred Nalugoda; Mary P Meehan; Rhoda Ashley Morrow; Maria J Wawer Journal: J Infect Dis Date: 2003-10-28 Impact factor: 5.226
Authors: Vivian F Go; C Johnson Sethulakshmi; Margaret E Bentley; Sudha Sivaram; A K Srikrishnan; Suniti Solomon; David D Celentano Journal: AIDS Behav Date: 2003-09
Authors: Subadra Panchanadeswaran; Sethulakshmi C Johnson; Sudha Sivaram; A K Srikrishnan; Carl Latkin; Margaret E Bentley; Suniti Solomon; Vivian F Go; David Celentano Journal: Int J Drug Policy Date: 2008-01-09
Authors: Sharon A Abbott; Barbara A Friedland; Avina Sarna; Lauren L Katzen; Ulrike Rawiel; Aylur K Srikrishnan; C S Shalini; Waimar Tun; Christine A Kelly; Suniti Solomon; Barbara S Mensch Journal: AIDS Behav Date: 2013-07
Authors: Purnima Madhivanan; Karl Krupp; Jill Hardin; Chitra Karat; Jeffrey D Klausner; Arthur L Reingold Journal: Trop Med Int Health Date: 2009-04-20 Impact factor: 2.622
Authors: Sujit D Rathod; Tan Li; Jeffrey D Klausner; Alan Hubbard; Arthur L Reingold; Purnima Madhivanan Journal: BMC Med Inform Decis Mak Date: 2015-12-16 Impact factor: 2.796